ArticleInternational journal of hematology2025
Peripheral T cell lymphoma following CD19-targeted chimeric antigen receptor T cell therapy.
Hiro Tatetsu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it